首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Immunohistochemical criteria for endometrial receptivity in I/II stage endometriosis IVF-treated patients
【24h】

Immunohistochemical criteria for endometrial receptivity in I/II stage endometriosis IVF-treated patients

机译:I / II期子宫内膜异位症IVF治疗患者子宫内膜接受性的免疫组织化学标准

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

sBackground: Implantation failure of in vitro fertilization (IVF) cycles is recognized as one of key problems in contemporary reproductive medicine. Implantation itself is a multifactorial process and one can hardly expect to find a single criterion for the endometrium receptivity. Endometrium biopsy still remains the most applicable technique to diagnose abnormalities causing decrease or complete loss of endometrial receptivity.Materials and methods: We have studied 95 endometrial biopsy samples from 45 patient with I/II stage endometriosis and 40 controls from October 2014 to December 2015. Immunohistochemical analysis of key biological molecules participating in implant window formation (LIF, ER, PR, integrin, TGF-1 and VEGF) was done to assess their predicting value for endometrial receptivity troubles.Results: The discriminant analysis demonstrated that highest information capacity was characteristic for LIF expression percent area, integrin V3 both percent area and optic density in endometrial stroma and glands and finally TGF1 and VEGF-? percent area expression in endometrial stroma. The model test done on a checking group showed 89.1% correct discrimination. Cross-checking in a teaching group showed a bit lower but still high correct answer percentage (88.8%). A decision-making classification tree was worked out.Conclusion: The produced model is sufficient for predicting IVF treatment failure and allows producing reasonable treatment tactics as well as encourages IVF treatment effectiveness improvement in patients with endometriosis.
机译:s背景:体外受精(IVF)周期的植入失败被认为是当代生殖医学的关键问题之一。植入本身是一个多因素过程,几乎不能期望找到子宫内膜接受性的单一标准。子宫内膜活检仍是最可用于诊断导致子宫内膜容受性降低或完全丧失的异常的技术。材料与方法:自2014年10月至2015年12月,我们研究了45例I / II期子宫内膜异位患者和40例对照的95例子宫内膜活检样本。免疫组织化学分析了参与植入窗口形成的关键生物分子(LIF,ER,PR,整联蛋白,TGF-1和VEGF),以评估其对子宫内膜容受性障碍的预测价值。结果:判别分析表明,最高的信息容量是特征子宫内膜基质和腺体中LIF表达的百分比面积,整联蛋白V3的面积百分比和视密度,最后是TGF1和VEGF-β子宫内膜间质的面积表达百分比。在一个检查组上进行的模型测试显示正确识别率为89.1%。在一个教学小组中进行交叉核对显示正确答案的百分比较低,但仍然很高(88.8%)。结论:所产生的模型足以预测IVF治疗失败,并能产生合理的治疗策略,并鼓励子宫内膜异位症患者IVF治疗效果的改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号